Management updates in PsA and axSpA

Introduction

Take This Event

Management updates in PsA and axSpA

Objectives

•Present current scientific evidence, including clinical trials, RealWorld data, and illustrative case studies, on the management of psoriatic arthritis and Axial spondylarthritis.
•Communicate Ixekizumab value proposition to highlight what the product may mean to people living with Psoriatic Arthritis or Axial spondylarthritis.

See Registration Policies, Cancellations & Refunds